ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q4Scopus Q3SCImago #18,297Hybrid

Journal of Pharmacy & Pharmacognosy Research

Identifier (ISSN):0719-4250(Print)
•
Publisher:Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA)
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
1– 0
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Journal of Pharmacy & Pharmacognosy Research

WoS Q4
01121.520231.220241202512026
Annual Impact Factor Metric
Current (2026):1
Scopus SJR & RankScopus Q3
0.271
#18,297

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
25

25 papers with at least that number of citations each

WoS: ESCIQ4
Self-Citation Rate16.7%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
77articles/year
97.14% Gold OA•91.11% Original Research

Aims & Scope

The Journal of Pharmacy & Pharmacognosy Research (JPPRes) is an international, specialized and peer-reviewed open access journal, under the auspices of AVAGAX – Diseño, Publicidad y Servicios Informáticos, which publishes studies in the pharmaceutical and herbal fields concerned with the physical, botanical, chemical, biological, toxicological properties and clinical applications of molecular entities, active pharmaceutical ingredients, devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture, evaluation and marketing. This journal publishes research papers, reviews, commentaries and letters to the editor as well as special issues and review of pre-and post-graduate thesis from pharmacists or professionals involved in Pharmaceutical Sciences or Pharmacognosy.

Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

PHARMACOLOGY & PHARMACY

Q4
Rank315/356
IndexESCI
JCIESCI2026

PHARMACOLOGY & PHARMACY

Q4
Rank296/356
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

4 year
2026Latest
IF1
Articles / Year—
Total Citations—
2025
IF1
Articles / Year—
Total Citations—
2024
IF1.2
Articles / Year—
Total Citations—
2023
IF1.5
Articles / Year—
Total Citations—

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #18,297Scopus Q3SCImago Profile
Scopus Coverage:2013-2025
Scopus Broad Areas:Health ProfessionsMedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q3
0.271

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
1.40

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,639 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations465
3-Year Documents295
Citable Documents294

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate50.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Complementary and Alternative MedicineQ3
Pharmaceutical ScienceQ3
PharmacologyQ3
PharmacyQ3
Drug DiscoveryQ4
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 16.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Pharmacy & Pharmacognosy Research (ISSN: 0719-4250) is a peer-reviewed international scholarly journal in the field of PHARMACOLOGY & PHARMACY, published by Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA) in Chile. The periodical holds a Journal Impact Factor (JIF) of 1.00, ranking in quartile Q4 of Web of Science (ESCI), a Scopus SJR indicator of 0.271 (Q3), an H-index of 25.

The journal enforces rigorous peer evaluation with an annual output of approximately 77 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,639 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA)
Publication Language
English, Spanish
Frequency
Periodic
Indexing & Databases
ESCIScopusDOAJPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: d3c3fbd8-4c1b-41f7-b3a6-4a80b79dd3cf
Database Updated: 2026-09-28